Gemcitabine Hydrochloride in Treating Patients With Locally Advanced Pancreatic Cancer
Status:
Completed
Trial end date:
2015-10-30
Target enrollment:
Participant gender:
Summary
This phase I trial studies the side effects and best dose of gemcitabine hydrochloride in
treating patients with locally advanced pancreatic cancer. Drugs used in chemotherapy, such
as gemcitabine hydrochloride, work in different ways to stop the growth of tumor cells,
either by killing the cells or by stopping them from dividing.